VINCERX PHARMA

vincerx-pharma-logo

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage bioconjugation/next-generation antibody-drug conjugate platform.

#SimilarOrganizations #People #Website #More

VINCERX PHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science Oncology

Founded:
2018-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.vincerx.com

Total Employee:
11+

Status:
Active

Total Funding:
16.5 M USD

Technology used in webpage:
LetsEncrypt IPv6 COVID-19 Mobile Optimized New Relic Akamai Hosted Drupal Adobe Dynamic Tag Management Visual Composer Ultimate Addons Akamai EdgeConnect


Similar Organizations

adgero-biopharmaceuticals-logo

Adgero Biopharmaceuticals

Adgero Biopharmaceuticals, Inc. is a privately-held biopharmaceutical company focused on building a robust pipeline

archerdx-logo

ArcherDX

ArcherDX is a biotechnology firm specializing in cancer research.

boston-oncology-logo

Boston Oncology

Boston Oncology is a healthcare of citizens in emerging markets around the world through regional development and production of licensed

boxone-ventures-logo

BoxOne Ventures

Private investment firm led by entrepreneurs. We invest in early-stage companies across all sectors around the world.

nephrodi-therapeutics-logo

NephroDI Therapeutics

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

pci-pharma-services-logo

PCI Pharma Services

PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.

pinpoint-therapeutics-logo

Pinpoint Therapeutics

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

stabiliz-orthopaedics-logo

Stabiliz Orthopaedics

Stabiliz Orthopaedics develops novel enhancements for orthopedic medical devices using FDA-approved technologies.

tot-biopharm-logo

TOT BIOPHARM

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.


Current Advisors List

christopher-lowe_image

Christopher Lowe Board Member @ Vincerx Pharma
Board_member
2020-12-01

Current Employees Featured

raquel-izumi_image

Raquel Izumi
Raquel Izumi President & COO @ Vincerx Pharma
President & COO
2020-06-01

not_available_image

Ahmed M. Hamdy
Ahmed M. Hamdy Founder & Chief Executive Officer @ Vincerx Pharma
Founder & Chief Executive Officer

tom-thomas_image

Tom Thomas
Tom Thomas General Counsel and Chief Legal Officer @ Vincerx Pharma
General Counsel and Chief Legal Officer
2021-03-01

Founder


not_available_image

Ahmed M. Hamdy

raquel-izumi_image

Raquel Izumi

Stock Details


Company's stock symbol is NASDAQ:VINC

Official Site Inspections

http://www.vincerx.com Semrush global rank: 5.1 M Semrush visits lastest month: 1.57 K

  • Host name: cloudproxy10127.sucuri.net
  • IP address: 192.124.249.127
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vincerx Pharma"

CORPORATE OVERVIEW - Vincerx

AG and further modifications by Vincerx, Inc. Permission is granted to copy, distribute and/or modify this figure under the terms of the GNU Free Documentation License, Version 1.3. After …See details»

Vincerx Pharma - Crunchbase Company Profile & Funding

Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies …See details»

Our Team | Vincerx Pharma

Before joining Vincerx, Dr Lerchen was a Distinguished Fellow in the Bayer Science Fellow Network of the Pharmaceuticals R&D organization of Bayer AG. With 33 years background in …See details»

CORPORATE OVERVIEW - Vincerx Pharma

Underlying Vincerx’s expectations regarding its future business or business model; Vincerx’s ability to successfully develop and commercialize product candidates; Vincerx’s capital …See details»

Vincerx Pharma, Inc. (VINC) - Yahoo Finance Canada

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. …See details»

Vincerx Pharma - LinkedIn

Vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the ...See details»

Vincerx Pharma - Contacts, Employees, Board Members

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology. ... Experience the new Crunchbase, powered by AI . …See details»

Vincerx Pharma - Funding, Financials, Valuation & Investors

Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology. Search Crunchbase. ... How much funding has this …See details»

Vincerx Pharma, Inc. - Drug pipelines, Patents, Clinical trials

Explore Vincerx Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 58 news, and 7 literature, Disease Domain:Neoplasms, Hemic and Lymphatic …See details»

Vincerx Pharma Overview | SignalHire Company Profile

Vincerx Pharma (Vincerx) ... Organization Website: vincerx.com : Social Links: Vincerx Pharma industries Pharma: Headquarters Location: 260 Sheridan Ave, Palo Alto, California, 94306 US ...See details»

Vincera Pharma Announces Name Change to Vincerx - Yahoo …

Jan 7, 2021 Vincerx’s executive team has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and …See details»

News Releases - Vincerx Pharma

Jan 23, 2025 Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258. Jan 23, 2025 Vincerx Pharma, Inc. Announces Reverse …See details»

Vincera Pharma Announces Name Change to Vincerx - Vincerx …

PALO ALTO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with …See details»

Culture & Careers | Vincerx Pharma

At Vincerx, we are passionate about our work family. We pledged to create an open, aware, and accepting workplace and, by extension, a responsive, innovative, and successful company. …See details»

Vincerx Pharma Announces Merger, Leadership Changes, and …

Dec 27, 2024 Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, focused on developing novel therapies to address unmet medical needs in …See details»

Vincerx Pharma, Inc. (VINC)

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. …See details»

Pipeline | Vincerx Pharma

Bioconjugation Platform. Antibody-drug conjugates (ADCs) are an established therapeutic approach in oncology used to selectively deliver potent cytotoxins directly to tumor cells, with …See details»

Vincerx, left in limbo by collapsed deal, moves to merge with AI ...

Mar 18, 2025 Vincerx had $3.9 million in cash when the Oqory merger imploded and predicted its cash runway would run into late in the second quarter. Needing to move fast, the biotech …See details»

Vincerx Pharma Announces Non-Binding Letter of Intent for …

SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has entered into a non-binding letter of intent (“LOI”) with …See details»

Vincerx Pharma Shares Soar on Proposed Merger with Global …

Mar 18, 2025 Shares of Vincerx rose 45% higher at $1.20. The clinical stage biopharmaceutical company said Tuesday that has entered into a non-binding letter of intent with Global Digital, …See details»

linkstock.net © 2022. All rights reserved